紫杉醇和卡铂联合或不联合贝伐珠单抗治疗 II 期、III 期或 IV 期卵巢上皮癌、原发性腹膜癌或输卵管癌患者
GOG-0262:每 3 周一次紫杉醇与每周一次密集剂量紫杉醇联合卡铂联合或不联合贝伐珠单抗(NSC #704865)治疗原发性 II、III 或 IV 期上皮性卵巢癌的 III 期试验,腹膜或输卵管癌和 ACRIN 6695:灌注 CT 成像评估参与 GOG-0262 患者的治疗反应
This phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin with or without bevacizumab in treating patients with stage II, III or IV ovarian epithelial cancer, primary peritoneal cancer, or fallopian tube cancer. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab is a type of drug called a monoclonal antibody and blocks tumor growth by stopping the growth of blood vessels that tumors need to grow. It is not yet known whether giving paclitaxel with combination chemotherapy once every three weeks is more effective than giving paclitaxel once a week in treating patients with ovarian, primary peritoneal, or fallopian tube cancer.
研究概览
地位
条件
- 卵巢子宫内膜样腺癌
- 卵巢浆液性癌
- 卵巢未分化癌
- 卵巢粘液腺癌
- 输卵管移行细胞癌
- 卵巢移行细胞癌
- 输卵管子宫内膜样腺癌
- 输卵管粘液腺癌
- 卵巢浆液性腺癌
- 原发性腹膜浆液性腺癌
- IIA 期输卵管癌 AJCC v6 和 v7
- IIA 期卵巢癌 AJCC V6 和 v7
- IIB 期输卵管癌 AJCC v6 和 v7
- IIB 期卵巢癌 AJCC v6 和 v7
- IIC 期输卵管癌 AJCC v6 和 v7
- IIC 期卵巢癌 AJCC v6 和 v7
- IIIA 期输卵管癌 AJCC v7
- IIIA 期卵巢癌 AJCC v6 和 v7
- IIIA 期原发性腹膜癌 AJCC v7
- IIIB 期输卵管癌 AJCC v7
- IIIB 期卵巢癌 AJCC v6 和 v7
- IIIB 期原发性腹膜癌 AJCC v7
- IIIC 期输卵管癌 AJCC v7
- IIIC 期卵巢癌 AJCC v6 和 v7
- IIIC 期原发性腹膜癌 AJCC v7
- IV 期输卵管癌 AJCC v6 和 v7
- IV 期卵巢癌 AJCC v6 和 v7
- IV 期原发性腹膜癌 AJCC v7
- 卵巢布伦纳瘤
- 卵巢透明细胞腺癌纤维瘤
详细说明
PRIMARY OBJECTIVES:
I. To determine if the weekly paclitaxel regimen increases the time until first progression or death (progression-free survival [PFS]) compared to the every-3-week paclitaxel regimen in women with primary stage II, III or IV epithelial ovarian, peritoneal or fallopian tube cancer who are receiving carboplatin with or without bevacizumab.
SECONDARY OBJECTIVES:
I. To determine if the weekly paclitaxel increases the duration of overall survival compared to the every-3-week paclitaxel when combined with carboplatin with or without bevacizumab.
II. To compare the weekly paclitaxel to the every-3-week paclitaxel with respect to the incidence of severe or serious adverse events when it is combined with carboplatin with or without bevacizumab.
III. To compare the weekly paclitaxel to the every-3-week paclitaxel with respect to patients' self-reported quality of life (QOL) as measured by the Functional Assessment of Cancer Therapy-Ovarian (FACT-O)-Trial Outcome Index (TOI), when paclitaxel is combined with carboplatin with or without bevacizumab. (As of 02/08/2012, the QOL portion of this study is complete; patients enrolled after this date will not have QOL assessments)
TRANSLATIONAL RESEARCH OBJECTIVES:
I. To evaluate single nucleotide polymorphisms (SNPs) associated with progression-free survival and toxicity in advanced stage epithelial ovarian, peritoneal and fallopian tube cancer using genome wide association studies (GWAS).* II. To evaluate genomic signatures in tumor tissues which are predictive for patient survival in advanced stage epithelial ovarian, peritoneal and fallopian tube cancer.* III. To evaluate the association between serum and plasma biomarkers and response to anti-angiogenesis therapy in advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer.*
NOTE: *As of 02/08/2012, the translational research (TR) portion of this study is complete; patients enrolled after this date will not have TR specimens collected.
IMAGING PRIMARY OBJECTIVES:
I. To determine whether larger changes in the tumor perfusion parameters from baseline timepoint (T0) to early-therapy T2 are prognostic of higher progression-free survival (PFS) rate at 6 months (PFS-6) from enrollment in patients treated with weekly or every-3-week paclitaxel regimens, who are receiving carboplatin with or without bevacizumab.***
IMAGING SECONDARY OBJECTIVES:
I. To determine whether larger changes in tumor perfusion parameters from baseline T0 to intermediate T1 and from T1 to T2 are prognostic of higher PFS-6 in patients treated with weekly or every-3-week paclitaxel regimens, who are receiving carboplatin with or without bevacizumab.*** II. To determine whether larger changes in tumor perfusion parameters values from T0 to T1, T0 to T2, and T1 to T2 are prognostic of better overall survival in all treatment arms.*** III. To assess the association between changes in tumor perfusion parameters before and after chemotherapy initiation (T0 to T1) and subsequent best tumor response according to standard anatomic Response Evaluation Criteria in Solid Tumors (RECIST).*** IV. To assess the association between tumor perfusion parameters before chemotherapy and subsequent best tumor response according to RECIST, PFS-6, and overall survival.*** V. To test the assumption that tumor perfusion parameters are reliable, user-independent, and reproducible parameters of tumor microvascular characteristics; a subgroup of 15 patients will have repeat computed tomography (CT) perfusion studies at the intermediate T1 time point.***
NOTE: ***Patients enrolled after February 8, 2012 must participate in the ACRIN 6695 component at ACRIN-qualified institutions.
OUTLINE: Patients are randomized to 1 of 2 treatment arms (beginning on 04-30-2012, the trial is no longer randomized and the chemotherapy regimen is selected and declared prior to enrolling in the study).
ARM I (adjuvant chemotherapy suboptimally debulked): Patients receive paclitaxel intravenously (IV) over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses.
ARM II (neoadjuvant chemotherapy with interval cytoreductive surgery): Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Patients undergo interval cytoreductive surgery between courses 3 and 4.
Patients in both arms may receive optional** bevacizumab IV over 30-90 minutes on day 1 beginning in course 2. Courses of bevacizumab repeat every 21 days in the absence of disease progression or unacceptable toxicity. Patients in Arm II receive bevacizumab during courses 2, 5, and 6 only.
NOTE: **Before enrolling onto this study, each patient chooses whether the study treatment will include concurrent and maintenance bevacizumab.
After completion of study treatment, patients are followed up every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
研究类型
注册 (实际的)
阶段
- 第三阶段
联系人和位置
学习地点
-
-
Ontario
-
Toronto、Ontario、加拿大、M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
-
-
Alabama
-
Birmingham、Alabama、美国、35233
- University of Alabama at Birmingham Cancer Center
-
Mobile、Alabama、美国、36688
- University of South Alabama Mitchell Cancer Institute
-
-
Alaska
-
Anchorage、Alaska、美国、99508
- Providence Alaska Medical Center
-
-
Arizona
-
Phoenix、Arizona、美国、85013
- Saint Joseph's Hospital and Medical Center
-
Scottsdale、Arizona、美国、85259
- Mayo Clinic in Arizona
-
Tucson、Arizona、美国、85704
- University of Arizona Cancer Center-Orange Grove Campus
-
Tucson、Arizona、美国、85719
- Banner University Medical Center - Tucson
-
Tucson、Arizona、美国、85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Hot Springs、Arkansas、美国、71913
- CHI Saint Vincent Cancer Center Hot Springs
-
Little Rock、Arkansas、美国、72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch、California、美国、94531
- Kaiser Permanente-Deer Valley Medical Center
-
Burbank、California、美国、91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Castro Valley、California、美国、94546
- East Bay Radiation Oncology Center
-
Castro Valley、California、美国、94546
- Valley Medical Oncology Consultants-Castro Valley
-
Concord、California、美国、94520
- John Muir Medical Center-Concord
-
Emeryville、California、美国、94608
- Bay Area Breast Surgeons Inc
-
Fremont、California、美国、94538
- Kaiser Permanente-Fremont
-
Fremont、California、美国、94538
- Valley Medical Oncology Consultants-Fremont
-
Fresno、California、美国、93720
- Kaiser Permanente-Fresno
-
Greenbrae、California、美国、94904
- Marin Cancer Care Inc
-
La Jolla、California、美国、92093
- UC San Diego Moores Cancer Center
-
Long Beach、California、美国、90806
- Long Beach Memorial Medical Center-Todd Cancer Institute
-
Los Angeles、California、美国、90048
- Cedars-Sinai Medical Center
-
Los Angeles、California、美国、90095
- UCLA / Jonsson Comprehensive Cancer Center
-
Los Angeles、California、美国、90027
- Kaiser Permanente Los Angeles Medical Center
-
Martinez、California、美国、94553-3156
- Contra Costa Regional Medical Center
-
Mountain View、California、美国、94040
- El Camino Hospital
-
Mountain View、California、美国、94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
Oakland、California、美国、94611
- Kaiser Permanente-Oakland
-
Oakland、California、美国、94611
- Kaiser Permanente Oakland-Broadway
-
Oakland、California、美国、94609
- Alta Bates Summit Medical Center - Summit Campus
-
Oakland、California、美国、94609
- Hematology and Oncology Associates-Oakland
-
Oakland、California、美国、94609
- Tom K Lee Inc
-
Oakland、California、美国、94609
- Bay Area Tumor Institute
-
Oakland、California、美国、94602
- Wilma Chan Highland Hospital
-
Palo Alto、California、美国、94304
- Stanford Cancer Institute Palo Alto
-
Rancho Cordova、California、美国、95670
- Kaiser Permanente-Rancho Cordova Cancer Center
-
Redwood City、California、美国、94063
- Kaiser Permanente-Redwood City
-
Richmond、California、美国、94801
- Kaiser Permanente-Richmond
-
Rohnert Park、California、美国、94928
- Rohnert Park Cancer Center
-
Roseville、California、美国、95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville、California、美国、95661
- Kaiser Permanente-Roseville
-
Roseville、California、美国、95661
- Sutter Roseville Medical Center
-
Sacramento、California、美国、95816
- Sutter Medical Center Sacramento
-
Sacramento、California、美国、95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento、California、美国、95823
- Kaiser Permanente-South Sacramento
-
Sacramento、California、美国、95823
- South Sacramento Cancer Center
-
Sacramento、California、美国、95825
- Kaiser Permanente Sacramento Medical Center
-
San Diego、California、美国、92123
- Sharp Memorial Hospital
-
San Francisco、California、美国、94115
- Kaiser Permanente-San Francisco
-
San Francisco、California、美国、94115
- UCSF Medical Center-Mount Zion
-
San Jose、California、美国、95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro、California、美国、94577
- Kaiser Permanente San Leandro
-
San Pablo、California、美国、94806
- Doctors Medical Center- JC Robinson Regional Cancer Center
-
San Rafael、California、美国、94903
- Kaiser Permanente-San Rafael
-
Santa Clara、California、美国、95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa、California、美国、95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco、California、美国、94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco、California、美国、94080
- Kaiser Permanente-South San Francisco
-
Stockton、California、美国、95210
- Kaiser Permanente-Stockton
-
Sylmar、California、美国、91342
- Olive View-University of California Los Angeles Medical Center
-
Vacaville、California、美国、95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo、California、美国、94589
- Kaiser Permanente-Vallejo
-
Walnut Creek、California、美国、94596
- Kaiser Permanente-Walnut Creek
-
Walnut Creek、California、美国、94598
- John Muir Medical Center-Walnut Creek
-
-
Colorado
-
Aurora、Colorado、美国、80045
- UCHealth University of Colorado Hospital
-
Denver、Colorado、美国、80205
- Kaiser Permanente-Franklin
-
Englewood、Colorado、美国、80110
- Rocky Mountain Gynecologic Oncology PC
-
Fort Collins、Colorado、美国、80524
- Poudre Valley Hospital
-
Lafayette、Colorado、美国、80026
- Kaiser Permanente-Rock Creek
-
-
Connecticut
-
Bridgeport、Connecticut、美国、06606
- Hartford HealthCare - Saint Vincent's Medical Center
-
Danbury、Connecticut、美国、06810
- Danbury Hospital
-
Hartford、Connecticut、美国、06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
Hartford、Connecticut、美国、06102
- Hartford Hospital
-
New Britain、Connecticut、美国、06050
- The Hospital of Central Connecticut
-
New Haven、Connecticut、美国、06520
- Yale University
-
Norwich、Connecticut、美国、06360
- Eastern Connecticut Hematology and Oncology Associates
-
Stamford、Connecticut、美国、06904
- Stamford Hospital/Bennett Cancer Center
-
-
Delaware
-
Lewes、Delaware、美国、19958
- Beebe Medical Center
-
Newark、Delaware、美国、19718
- Christiana Care Health System-Christiana Hospital
-
-
District of Columbia
-
Washington D.C.、District of Columbia、美国、20010
- MedStar Washington Hospital Center
-
Washington D.C.、District of Columbia、美国、20016
- Sibley Memorial Hospital
-
-
Florida
-
Clearwater、Florida、美国、33756
- Morton Plant Hospital
-
Fort Lauderdale、Florida、美国、33316
- Broward Health Medical Center
-
Fort Myers、Florida、美国、33905
- GenesisCare USA - FGO
-
Jacksonville、Florida、美国、32224-9980
- Mayo Clinic in Florida
-
Jacksonville、Florida、美国、32204
- Southeast Gynecologic Oncology Associates
-
Lakeland、Florida、美国、33805
- The Watson Clinic
-
Orlando、Florida、美国、32806
- Orlando Health Cancer Institute
-
Orlando、Florida、美国、32803
- AdventHealth Orlando
-
St. Petersburg、Florida、美国、33713
- Women's Cancer Associates
-
-
Georgia
-
Atlanta、Georgia、美国、30342
- Northside Hospital
-
Gainesville、Georgia、美国、30501
- Northeast Georgia Medical Center-Gainesville
-
Macon、Georgia、美国、31201
- Central Georgia Gynecologic Oncology
-
Savannah、Georgia、美国、31404
- Memorial Health University Medical Center
-
-
Hawaii
-
Honolulu、Hawaii、美国、96813
- Queen's Medical Center
-
Honolulu、Hawaii、美国、96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu、Hawaii、美国、96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu、Hawaii、美国、96813
- Straub Clinic and Hospital
-
Honolulu、Hawaii、美国、96813
- University of Hawaii Cancer Center
-
Honolulu、Hawaii、美国、96817
- Queen's Cancer Center - Kuakini
-
Honolulu、Hawaii、美国、96826
- Kapiolani Medical Center for Women and Children
-
Honolulu、Hawaii、美国、96819
- Kaiser Permanente Moanalua Medical Center
-
Lihue、Hawaii、美国、96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
Wailuku、Hawaii、美国、96793
- Maui Memorial Medical Center
-
Wailuku、Hawaii、美国、96793
- Pacific Cancer Institute of Maui
-
‘Aiea、Hawaii、美国、96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise、Idaho、美国、83706
- Saint Alphonsus Cancer Care Center-Boise
-
Post Falls、Idaho、美国、83854
- Kootenai Clinic Cancer Services - Post Falls
-
-
Illinois
-
Aurora、Illinois、美国、60504
- Rush-Copley Medical Center
-
Bloomington、Illinois、美国、61704
- Illinois CancerCare-Bloomington
-
Bloomington、Illinois、美国、61701
- OSF Saint Joseph Medical Center
-
Canton、Illinois、美国、61520
- Illinois CancerCare-Canton
-
Canton、Illinois、美国、61520
- Graham Hospital Association
-
Carthage、Illinois、美国、62321
- Illinois CancerCare-Carthage
-
Carthage、Illinois、美国、62321
- Memorial Hospital
-
Chicago、Illinois、美国、60611
- Northwestern University
-
Chicago、Illinois、美国、60637
- University of Chicago Comprehensive Cancer Center
-
Chicago、Illinois、美国、60612
- John H Stroger Jr Hospital of Cook County
-
Chicago、Illinois、美国、60631
- Presence Resurrection Medical Center
-
Chicago、Illinois、美国、60612
- Rush MD Anderson Cancer Center
-
Decatur、Illinois、美国、62526
- Decatur Memorial Hospital
-
Decatur、Illinois、美国、62526
- Heartland Cancer Research NCORP
-
Elmhurst、Illinois、美国、60126
- Elmhurst Memorial Hospital
-
Eureka、Illinois、美国、61530
- Illinois CancerCare-Eureka
-
Eureka、Illinois、美国、61530
- Eureka Hospital
-
Galesburg、Illinois、美国、61401
- Illinois CancerCare-Galesburg
-
Havana、Illinois、美国、62644
- Mason District Hospital
-
Havana、Illinois、美国、62644
- Illinois CancerCare-Havana
-
Hinsdale、Illinois、美国、60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Kankakee、Illinois、美国、60901
- Presence Saint Mary's Hospital
-
Kewanee、Illinois、美国、61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb、Illinois、美国、61455
- Illinois CancerCare-Macomb
-
Macomb、Illinois、美国、61455
- Mcdonough District Hospital
-
Maywood、Illinois、美国、60153
- Loyola University Medical Center
-
Moline、Illinois、美国、61265
- Garneau, Stewart C MD (UIA Investigator)
-
Moline、Illinois、美国、61265
- Porubcin, Michael MD (UIA Investigator)
-
Moline、Illinois、美国、61265
- Spector, David MD (UIA Investigator)
-
Moline、Illinois、美国、61265
- Trinity Medical Center
-
Monmouth、Illinois、美国、61462
- Illinois CancerCare-Monmouth
-
Monmouth、Illinois、美国、61462
- Holy Family Medical Center
-
Normal、Illinois、美国、61761
- Carle Cancer Institute Normal
-
Normal、Illinois、美国、61761
- Illinois CancerCare-Community Cancer Center
-
Normal、Illinois、美国、61761
- Carle BroMenn Medical Center
-
Oak Lawn、Illinois、美国、60453-2699
- Advocate Christ Medical Center
-
Ottawa、Illinois、美国、61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa、Illinois、美国、61350
- Ottawa Regional Hospital and Healthcare Center
-
Park Ridge、Illinois、美国、60068
- Advocate Lutheran General Hospital
-
Pekin、Illinois、美国、61554
- Illinois CancerCare-Pekin
-
Pekin、Illinois、美国、61554
- OSF Saint Francis Radiation Oncology at Pekin
-
Peoria、Illinois、美国、61636
- Methodist Medical Center of Illinois
-
Peoria、Illinois、美国、61637
- OSF Saint Francis Medical Center
-
Peoria、Illinois、美国、61615
- Illinois CancerCare-Peoria
-
Peoria、Illinois、美国、61614
- Proctor Hospital
-
Peru、Illinois、美国、61354
- Illinois CancerCare-Peru
-
Peru、Illinois、美国、61354
- Illinois Valley Hospital
-
Princeton、Illinois、美国、61356
- Illinois CancerCare-Princeton
-
Princeton、Illinois、美国、61356
- Perry Memorial Hospital
-
Spring Valley、Illinois、美国、61362
- Illinois CancerCare-Spring Valley
-
Springfield、Illinois、美国、62781
- Springfield Memorial Hospital
-
Urbana、Illinois、美国、61801
- Carle Cancer Center
-
Warrenville、Illinois、美国、60555
- Northwestern Medicine Cancer Center Warrenville
-
Winfield、Illinois、美国、60190
- Northwestern Medicine Central DuPage Hospital
-
-
Indiana
-
Beech Grove、Indiana、美国、46107
- Franciscan Saint Francis Health-Beech Grove
-
Elkhart、Indiana、美国、46515
- Elkhart General Hospital
-
Elkhart、Indiana、美国、46514
- Michiana Hematology Oncology PC-Elkhart
-
Elkhart、Indiana、美国、46514-2098
- Elkhart Clinic
-
Fort Wayne、Indiana、美国、46845
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
-
Indianapolis、Indiana、美国、46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis、Indiana、美国、46260
- Ascension Saint Vincent Indianapolis Hospital
-
Kokomo、Indiana、美国、46904
- Community Howard Regional Health
-
La Porte、Indiana、美国、46350
- IU Health La Porte Hospital
-
Michigan City、Indiana、美国、46360
- Franciscan Saint Anthony Health-Michigan City
-
Mishawaka、Indiana、美国、46545
- Michiana Hematology Oncology PC-Mishawaka
-
Mishawaka、Indiana、美国、46545
- Saint Joseph Regional Medical Center-Mishawaka
-
Munster、Indiana、美国、46321
- The Community Hospital
-
Plymouth、Indiana、美国、46563
- Michiana Hematology Oncology PC-Plymouth
-
Richmond、Indiana、美国、47374
- Reid Health
-
South Bend、Indiana、美国、46601
- Memorial Hospital of South Bend
-
South Bend、Indiana、美国、46628
- Northern Indiana Cancer Research Consortium
-
South Bend、Indiana、美国、46617
- South Bend Clinic
-
Westville、Indiana、美国、46391
- Michiana Hematology Oncology PC-Westville
-
-
Iowa
-
Ames、Iowa、美国、50010
- McFarland Clinic - Ames
-
Bettendorf、Iowa、美国、52722
- Constantinou, Costas L MD (UIA Investigator)
-
Cedar Rapids、Iowa、美国、52403
- Mercy Hospital
-
Cedar Rapids、Iowa、美国、52403
- Oncology Associates at Mercy Medical Center
-
Clive、Iowa、美国、50325
- Mercy Cancer Center-West Lakes
-
Clive、Iowa、美国、50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Des Moines、Iowa、美国、50309
- Iowa Methodist Medical Center
-
Des Moines、Iowa、美国、50314
- Mercy Medical Center - Des Moines
-
Des Moines、Iowa、美国、50316
- Iowa Lutheran Hospital
-
Des Moines、Iowa、美国、50309
- Iowa-Wide Oncology Research Coalition NCORP
-
Des Moines、Iowa、美国、50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines、Iowa、美国、50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Iowa City、Iowa、美国、52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Mason City、Iowa、美国、50401
- Mercy Medical Center - North Iowa
-
Sioux City、Iowa、美国、51101
- Siouxland Regional Cancer Center
-
Sioux City、Iowa、美国、51102
- Mercy Medical Center-Sioux City
-
Sioux City、Iowa、美国、51104
- Saint Luke's Regional Medical Center
-
West Des Moines、Iowa、美国、50266-7700
- Methodist West Hospital
-
West Des Moines、Iowa、美国、50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City、Kansas、美国、66160
- University of Kansas Cancer Center
-
Overland Park、Kansas、美国、66209
- Menorah Medical Center
-
Overland Park、Kansas、美国、66213
- Saint Luke's South Hospital
-
Prairie Village、Kansas、美国、66208
- Kansas City NCI Community Oncology Research Program
-
-
Kentucky
-
Edgewood、Kentucky、美国、41017
- Saint Elizabeth Healthcare Edgewood
-
Lexington、Kentucky、美国、40536
- University of Kentucky/Markey Cancer Center
-
Lexington、Kentucky、美国、40503
- Baptist Health Lexington
-
Louisville、Kentucky、美国、40202
- Norton Hospital Pavilion and Medical Campus
-
Louisville、Kentucky、美国、40202
- The James Graham Brown Cancer Center at University of Louisville
-
Pikeville、Kentucky、美国、41501
- Pikeville Medical Center
-
-
Louisiana
-
Baton Rouge、Louisiana、美国、70817
- Woman's Hospital
-
New Orleans、Louisiana、美国、70112
- Tulane University School of Medicine
-
New Orleans、Louisiana、美国、70121
- Ochsner Medical Center Jefferson
-
New Orleans、Louisiana、美国、70112
- University Medical Center New Orleans
-
New Orleans、Louisiana、美国、70112
- Louisiana State University Health Science Center
-
Shreveport、Louisiana、美国、71103
- LSU Health Sciences Center at Shreveport
-
Shreveport、Louisiana、美国、71105
- Highland Clinic
-
-
Maine
-
Bangor、Maine、美国、04401
- Eastern Maine Medical Center
-
Portland、Maine、美国、04102
- MaineHealth Maine Medical Center - Portland
-
-
Maryland
-
Baltimore、Maryland、美国、21237
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute
-
Baltimore、Maryland、美国、21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore、Maryland、美国、21215
- Sinai Hospital of Baltimore
-
Baltimore、Maryland、美国、21204
- Greater Baltimore Medical Center
-
Baltimore、Maryland、美国、21201
- University of Maryland/Greenebaum Cancer Center
-
Easton、Maryland、美国、21601
- University of Maryland Shore Medical Center at Easton
-
Elkton、Maryland、美国、21921
- Christiana Care - Union Hospital
-
Silver Spring、Maryland、美国、20910
- Holy Cross Hospital
-
-
Massachusetts
-
Attleboro、Massachusetts、美国、02703
- Sturdy Memorial Hospital
-
Boston、Massachusetts、美国、02215
- Beth Israel Deaconess Medical Center
-
Boston、Massachusetts、美国、02215
- Dana-Farber Cancer Institute
-
Boston、Massachusetts、美国、02111
- Tufts Medical Center
-
Boston、Massachusetts、美国、02114
- Massachusetts General Hospital Cancer Center
-
Burlington、Massachusetts、美国、01805
- Lahey Clinic
-
Methuen、Massachusetts、美国、01844
- Holy Family Hospital
-
Springfield、Massachusetts、美国、01199
- Baystate Medical Center
-
Worcester、Massachusetts、美国、01605
- UMass Memorial Medical Center - Memorial Division
-
-
Michigan
-
Ann Arbor、Michigan、美国、48106
- Michigan Cancer Research Consortium NCORP
-
Ann Arbor、Michigan、美国、48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek、Michigan、美国、49017
- Bronson Battle Creek
-
Big Rapids、Michigan、美国、49307
- Spectrum Health Big Rapids Hospital
-
Dearborn、Michigan、美国、48124
- Corewell Health Dearborn Hospital
-
Detroit、Michigan、美国、48202
- Henry Ford Hospital
-
Detroit、Michigan、美国、48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit、Michigan、美国、48236
- Henry Ford Health Saint John Hospital
-
Escanaba、Michigan、美国、49829
- OSF Saint Francis Hospital and Medical Group
-
Flint、Michigan、美国、48532
- Genesys Regional Medical Center-West Flint Campus
-
Flint、Michigan、美国、48503
- Hurley Medical Center
-
Grand Blanc、Michigan、美国、48439
- Genesys Regional Medical Center
-
Grand Rapids、Michigan、美国、49503
- Cancer Research Consortium of West Michigan NCORP
-
Grand Rapids、Michigan、美国、49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids、Michigan、美国、49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Jackson、Michigan、美国、49201
- Allegiance Health
-
Kalamazoo、Michigan、美国、49007
- West Michigan Cancer Center
-
Kalamazoo、Michigan、美国、49007
- Bronson Methodist Hospital
-
Kalamazoo、Michigan、美国、49048
- Beacon Kalamazoo
-
Lansing、Michigan、美国、48912
- University of Michigan Health - Sparrow Lansing
-
Livonia、Michigan、美国、48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Muskegon、Michigan、美国、49444
- Trinity Health Muskegon Hospital
-
Niles、Michigan、美国、49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Pontiac、Michigan、美国、48341
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Port Huron、Michigan、美国、48060
- Lake Huron Medical Center
-
Royal Oak、Michigan、美国、48073
- Corewell Health William Beaumont University Hospital
-
Saginaw、Michigan、美国、48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph、Michigan、美国、49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph、Michigan、美国、49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Southfield、Michigan、美国、48075
- Henry Ford Health Providence Southfield Hospital
-
Traverse City、Michigan、美国、49684
- Munson Medical Center
-
Warren、Michigan、美国、48093
- Henry Ford Health Warren Hospital
-
Wyoming、Michigan、美国、49519
- University of Michigan Health - West
-
-
Minnesota
-
Bemidji、Minnesota、美国、56601
- Sanford Joe Lueken Cancer Center
-
Brainerd、Minnesota、美国、56401
- Essentia Health Saint Joseph's Medical Center
-
Burnsville、Minnesota、美国、55337
- Fairview Ridges Hospital
-
Coon Rapids、Minnesota、美国、55433
- Mercy Hospital
-
Duluth、Minnesota、美国、55805
- Saint Luke's Hospital of Duluth
-
Duluth、Minnesota、美国、55805
- Essentia Health Cancer Center
-
Duluth、Minnesota、美国、55805
- Essentia Health Saint Mary's Medical Center
-
Duluth、Minnesota、美国、55805
- Miller-Dwan Hospital
-
Edina、Minnesota、美国、55435
- Fairview Southdale Hospital
-
Fergus Falls、Minnesota、美国、56537
- Lake Region Healthcare Corporation-Cancer Care
-
Fridley、Minnesota、美国、55432
- Unity Hospital
-
Hutchinson、Minnesota、美国、55350
- Hutchinson Area Health Care
-
Maplewood、Minnesota、美国、55109
- Saint John's Hospital - Healtheast
-
Maplewood、Minnesota、美国、55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis、Minnesota、美国、55415
- Hennepin County Medical Center
-
Minneapolis、Minnesota、美国、55407
- Abbott-Northwestern Hospital
-
New Ulm、Minnesota、美国、56073
- New Ulm Medical Center
-
Robbinsdale、Minnesota、美国、55422
- North Memorial Medical Health Center
-
Rochester、Minnesota、美国、55905
- Mayo Clinic in Rochester
-
Saint Louis Park、Minnesota、美国、55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park、Minnesota、美国、55426
- Park Nicollet Frauenshuh Cancer Center
-
Saint Louis Park、Minnesota、美国、55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul、Minnesota、美国、55101
- Regions Hospital
-
Saint Paul、Minnesota、美国、55102
- United Hospital
-
Shakopee、Minnesota、美国、55379
- Saint Francis Regional Medical Center
-
Stillwater、Minnesota、美国、55082
- Lakeview Hospital
-
Waconia、Minnesota、美国、55387
- Ridgeview Medical Center
-
Willmar、Minnesota、美国、56201
- Rice Memorial Hospital
-
Woodbury、Minnesota、美国、55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Mississippi
-
Jackson、Mississippi、美国、39216
- University of Mississippi Medical Center
-
Jackson、Mississippi、美国、39216
- Saint Dominic-Jackson Memorial Hospital
-
-
Missouri
-
Joplin、Missouri、美国、64804
- Freeman Health System
-
Kansas City、Missouri、美国、64116
- North Kansas City Hospital
-
Kansas City、Missouri、美国、64111
- Saint Luke's Hospital of Kansas City
-
Kansas City、Missouri、美国、64132
- Research Medical Center
-
Kansas City、Missouri、美国、64118
- Heartland Hematology and Oncology Associates Incorporated
-
Kansas City、Missouri、美国、64114
- Saint Joseph Health Center
-
Lee's Summit、Missouri、美国、64086
- Saint Luke's East - Lee's Summit
-
Liberty、Missouri、美国、64068
- Liberty Hospital
-
Saint Joseph、Missouri、美国、64506
- Heartland Regional Medical Center
-
Springfield、Missouri、美国、65804
- Cancer Research for the Ozarks NCORP
-
Springfield、Missouri、美国、65807
- CoxHealth South Hospital
-
Springfield、Missouri、美国、65804
- Mercy Hospital Springfield
-
St Louis、Missouri、美国、63110
- Washington University School of Medicine
-
-
Montana
-
Billings、Montana、美国、59101
- Billings Clinic Cancer Center
-
Billings、Montana、美国、59101
- Saint Vincent Healthcare
-
Billings、Montana、美国、59102
- Montana Cancer Consortium NCORP
-
Billings、Montana、美国、59102
- Saint Vincent Frontier Cancer Center
-
Bozeman、Montana、美国、59715
- Bozeman Health Deaconess Hospital
-
Butte、Montana、美国、59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls、Montana、美国、59405
- Great Falls Clinic
-
Great Falls、Montana、美国、59405
- Benefis Sletten Cancer Institute
-
Havre、Montana、美国、59501
- Northern Montana Hospital
-
Helena、Montana、美国、59601
- Saint Peter's Community Hospital
-
Kalispell、Montana、美国、59901
- Glacier Oncology PLLC
-
Kalispell、Montana、美国、59901
- Kalispell Medical Oncology
-
Kalispell、Montana、美国、59901
- Logan Health Medical Center
-
Missoula、Montana、美国、59802
- Saint Patrick Hospital - Community Hospital
-
Missoula、Montana、美国、59802
- Montana Cancer Specialists
-
-
Nebraska
-
Kearney、Nebraska、美国、68847
- CHI Health Good Samaritan
-
Lincoln、Nebraska、美国、68510
- Nebraska Cancer Research Center
-
Omaha、Nebraska、美国、68114
- Nebraska Methodist Hospital
-
Omaha、Nebraska、美国、68198
- University of Nebraska Medical Center
-
Omaha、Nebraska、美国、68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha、Nebraska、美国、68122
- Alegent Health Immanuel Medical Center
-
Omaha、Nebraska、美国、68130
- Alegent Health Lakeside Hospital
-
Omaha、Nebraska、美国、68106
- Missouri Valley Cancer Consortium
-
-
Nevada
-
Las Vegas、Nevada、美国、89106
- Women's Cancer Center of Nevada
-
Reno、Nevada、美国、89502
- Renown Regional Medical Center
-
Reno、Nevada、美国、89502
- Center of Hope at Renown Medical Center
-
-
New Jersey
-
Camden、New Jersey、美国、08103
- Cooper Hospital University Medical Center
-
Hackensack、New Jersey、美国、07601
- Hackensack University Medical Center
-
Morristown、New Jersey、美国、07960
- Morristown Medical Center
-
Mount Holly、New Jersey、美国、08060
- Virtua Memorial
-
Neptune City、New Jersey、美国、07753
- Jersey Shore Medical Center
-
Phillipsburg、New Jersey、美国、08865
- Saint Luke's Hospital-Warren Campus
-
Ridgewood、New Jersey、美国、07450
- Valley Health System Ridgewood Campus
-
Summit、New Jersey、美国、07902
- Overlook Hospital
-
Vineland、New Jersey、美国、08360
- Inspira Medical Center Vineland
-
Voorhees Township、New Jersey、美国、08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque、New Mexico、美国、87106
- Southwest Gynecologic Oncology Associates Inc
-
Albuquerque、New Mexico、美国、87106
- University of New Mexico Cancer Center
-
Las Cruces、New Mexico、美国、88011
- Memorial Medical Center-Las Cruces
-
-
New York
-
Albany、New York、美国、12208
- Women's Cancer Care Associates LLC
-
Brightwaters、New York、美国、11718
- Island Gynecologic Oncology
-
Brooklyn、New York、美国、11203
- State University of New York Downstate Medical Center
-
Buffalo、New York、美国、14263
- Roswell Park Cancer Institute
-
Jamaica、New York、美国、11432
- Queens Hospital Center
-
Lake Success、New York、美国、11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset、New York、美国、11030
- North Shore University Hospital
-
Middletown、New York、美国、10940
- Garnet Health Medical Center
-
Mineola、New York、美国、11501
- NYU Langone Hospital - Long Island
-
New Hyde Park、New York、美国、11040
- Long Island Jewish Medical Center
-
New York、New York、美国、10065
- Memorial Sloan Kettering Cancer Center
-
New York、New York、美国、10032
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
-
New York、New York、美国、10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Staten Island、New York、美国、10305
- Staten Island University Hospital
-
Stony Brook、New York、美国、11794
- Stony Brook University Medical Center
-
Syracuse、New York、美国、13210
- State University of New York Upstate Medical University
-
The Bronx、New York、美国、10461
- Montefiore Medical Center-Einstein Campus
-
-
North Carolina
-
Asheville、North Carolina、美国、28816
- Hope Women's Cancer Centers-Asheville
-
Burlington、North Carolina、美国、27215
- Cone Health Cancer Center at Alamance Regional
-
Chapel Hill、North Carolina、美国、27599
- UNC Lineberger Comprehensive Cancer Center
-
Charlotte、North Carolina、美国、28203
- Carolinas Medical Center/Levine Cancer Institute
-
Charlotte、North Carolina、美国、28204
- Novant Health Presbyterian Medical Center
-
Durham、North Carolina、美国、27710
- Duke University Medical Center
-
Goldsboro、North Carolina、美国、27534
- Wayne Memorial Hospital
-
Hendersonville、North Carolina、美国、28791
- Margaret R Pardee Memorial Hospital
-
Pinehurst、North Carolina、美国、28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Rutherfordton、North Carolina、美国、28139
- Rutherford Hospital
-
Wilmington、North Carolina、美国、28401
- Novant Health New Hanover Regional Medical Center
-
Winston-Salem、North Carolina、美国、27157
- Wake Forest University Health Sciences
-
-
North Dakota
-
Bismarck、North Dakota、美国、58501
- Sanford Bismarck Medical Center
-
Bismarck、North Dakota、美国、58501
- Mid Dakota Clinic
-
Bismarck、North Dakota、美国、58501
- Saint Alexius Medical Center
-
Fargo、North Dakota、美国、58122
- Sanford Roger Maris Cancer Center
-
Fargo、North Dakota、美国、58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Akron、Ohio、美国、44307
- Cleveland Clinic Akron General
-
Akron、Ohio、美国、44304
- Summa Health System - Akron Campus
-
Bellefontaine、Ohio、美国、43311
- Mary Rutan Hospital
-
Canton、Ohio、美国、44710
- Aultman Health Foundation
-
Chillicothe、Ohio、美国、45601
- Adena Regional Medical Center
-
Cincinnati、Ohio、美国、45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cincinnati、Ohio、美国、45220
- Good Samaritan Hospital - Cincinnati
-
Cleveland、Ohio、美国、44106
- Case Western Reserve University
-
Cleveland、Ohio、美国、44109
- MetroHealth Medical Center
-
Cleveland、Ohio、美国、44195
- Cleveland Clinic Foundation
-
Cleveland、Ohio、美国、44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus、Ohio、美国、43214
- Riverside Methodist Hospital
-
Columbus、Ohio、美国、43210
- Ohio State University Comprehensive Cancer Center
-
Columbus、Ohio、美国、43219
- The Mark H Zangmeister Center
-
Columbus、Ohio、美国、43228
- Doctors Hospital
-
Columbus、Ohio、美国、43215
- Grant Medical Center
-
Columbus、Ohio、美国、43222
- Mount Carmel Health Center West
-
Columbus、Ohio、美国、43215
- Columbus NCI Community Oncology Research Program
-
Dayton、Ohio、美国、45406
- Good Samaritan Hospital - Dayton
-
Dayton、Ohio、美国、45409
- Miami Valley Hospital
-
Dayton、Ohio、美国、45415
- Miami Valley Hospital North
-
Dayton、Ohio、美国、45405
- Grandview Hospital
-
Dayton、Ohio、美国、45459
- Dayton NCI Community Oncology Research Program
-
Delaware、Ohio、美国、43015
- Grady Memorial Hospital
-
Findlay、Ohio、美国、45840
- Blanchard Valley Hospital
-
Franklin、Ohio、美国、45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville、Ohio、美国、45331
- Wayne Hospital
-
Kettering、Ohio、美国、45429
- Kettering Medical Center
-
Lancaster、Ohio、美国、43130
- Fairfield Medical Center
-
Lima、Ohio、美国、45801
- Saint Rita's Medical Center
-
Marietta、Ohio、美国、45750
- Marietta Memorial Hospital
-
Mayfield Heights、Ohio、美国、44124
- Hillcrest Hospital Cancer Center
-
Mentor、Ohio、美国、44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Mount Vernon、Ohio、美国、43050
- Knox Community Hospital
-
Newark、Ohio、美国、43055
- Licking Memorial Hospital
-
Portsmouth、Ohio、美国、45662
- Southern Ohio Medical Center
-
Springfield、Ohio、美国、45504
- Springfield Regional Medical Center
-
Troy、Ohio、美国、45373
- Upper Valley Medical Center
-
Westerville、Ohio、美国、43081
- Saint Ann's Hospital
-
Wilmington、Ohio、美国、45177
- Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center
-
Xenia、Ohio、美国、45385
- Greene Memorial Hospital
-
Zanesville、Ohio、美国、43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City、Oklahoma、美国、73104
- University of Oklahoma Health Sciences Center
-
Tulsa、Oklahoma、美国、74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Bend、Oregon、美国、97701
- Saint Charles Health System
-
Portland、Oregon、美国、97239
- Oregon Health and Science University
-
Portland、Oregon、美国、97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland、Oregon、美国、97227
- Compass Oncology Rose Quarter
-
-
Pennsylvania
-
Abington、Pennsylvania、美国、19001
- Jefferson Abington Hospital
-
Allentown、Pennsylvania、美国、18103
- Lehigh Valley Hospital-Cedar Crest
-
Bethlehem、Pennsylvania、美国、18015
- Saint Luke's University Hospital-Bethlehem Campus
-
Bryn Mawr、Pennsylvania、美国、19010
- Bryn Mawr Hospital
-
Drexel Hill、Pennsylvania、美国、19026
- Delaware County Memorial Hospital
-
Hershey、Pennsylvania、美国、17033-0850
- Penn State Milton S Hershey Medical Center
-
Lancaster、Pennsylvania、美国、17602
- Lancaster General Hospital
-
Paoli、Pennsylvania、美国、19301
- Paoli Memorial Hospital
-
Philadelphia、Pennsylvania、美国、19111
- Fox Chase Cancer Center
-
Philadelphia、Pennsylvania、美国、19104
- University of Pennsylvania/Abramson Cancer Center
-
Philadelphia、Pennsylvania、美国、19140
- Temple University Hospital
-
Philadelphia、Pennsylvania、美国、19107
- Pennsylvania Hospital
-
Phoenixville、Pennsylvania、美国、19460
- Reading Hospital McGlinn Cancer Institute at Phoenixville
-
Pittsburgh、Pennsylvania、美国、15224
- West Penn Hospital
-
Pittsburgh、Pennsylvania、美国、15232
- UPMC Hillman Cancer Center
-
Pittsburgh、Pennsylvania、美国、15213
- UPMC-Magee Womens Hospital
-
Scranton、Pennsylvania、美国、18510
- Scranton Hematology Oncology
-
Scranton、Pennsylvania、美国、18501
- Mercy Hospital
-
Scranton、Pennsylvania、美国、18508
- Hematology and Oncology Associates of North East Pennsylvania
-
Upland、Pennsylvania、美国、19013
- Associates In Hematology Oncology PC-Upland
-
West Chester、Pennsylvania、美国、19380
- Chester County Hospital
-
West Reading、Pennsylvania、美国、19611
- Reading Hospital
-
Wynnewood、Pennsylvania、美国、19096
- Lankenau Medical Center
-
Wynnewood、Pennsylvania、美国、19096
- Main Line Health NCORP
-
-
Rhode Island
-
Providence、Rhode Island、美国、02905
- Women and Infants Hospital
-
-
South Carolina
-
Anderson、South Carolina、美国、29621
- AnMed Health Cancer Center
-
Anderson、South Carolina、美国、29621
- AnMed Health Hospital
-
Boiling Springs、South Carolina、美国、29316
- Prisma Health Cancer Institute - Spartanburg
-
Charleston、South Carolina、美国、29425
- Medical University of South Carolina
-
Greenville、South Carolina、美国、29605
- Prisma Health Cancer Institute - Faris
-
Greenville、South Carolina、美国、29615
- Prisma Health Cancer Institute - Eastside
-
Greenville、South Carolina、美国、29601
- Saint Francis Hospital
-
Spartanburg、South Carolina、美国、29303
- Spartanburg Medical Center
-
-
South Dakota
-
Rapid City、South Dakota、美国、57701
- Black Hills Obstetrics and Gynecology
-
Sioux Falls、South Dakota、美国、57105
- Avera Cancer Institute
-
Sioux Falls、South Dakota、美国、57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls、South Dakota、美国、57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Kingsport、Tennessee、美国、37660
- Wellmont Holston Valley Hospital and Medical Center
-
Knoxville、Tennessee、美国、37920
- University of Tennessee - Knoxville
-
-
Texas
-
Dallas、Texas、美国、75235
- Parkland Memorial Hospital
-
Dallas、Texas、美国、75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Fort Sam Houston、Texas、美国、78234
- Brooke Army Medical Center
-
Galveston、Texas、美国、77555-0565
- University of Texas Medical Branch
-
Houston、Texas、美国、77026-1967
- Lyndon Baines Johnson General Hospital
-
Houston、Texas、美国、77030
- UT MD Anderson Cancer Center
-
Houston、Texas、美国、77030
- Houston Methodist Hospital
-
Temple、Texas、美国、76508
- Scott and White Memorial Hospital
-
-
Utah
-
American Fork、Utah、美国、84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Cedar City、Utah、美国、84720
- Sandra L Maxwell Cancer Center
-
Logan、Utah、美国、84321
- Logan Regional Hospital
-
Murray、Utah、美国、84107
- Intermountain Medical Center
-
Ogden、Utah、美国、84403
- McKay-Dee Hospital Center
-
Provo、Utah、美国、84604
- Utah Valley Regional Medical Center
-
Salt Lake City、Utah、美国、84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City、Utah、美国、84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City、Utah、美国、84143
- LDS Hospital
-
Salt Lake City、Utah、美国、84103
- Intermountain Health Care
-
St. George、Utah、美国、84770
- Saint George Regional Medical Center
-
-
Vermont
-
Burlington、Vermont、美国、05401
- University of Vermont Medical Center
-
-
Virginia
-
Annandale、Virginia、美国、22003
- Northern Virginia Pelvic Surgery Associates
-
Charlottesville、Virginia、美国、22908
- University of Virginia Cancer Center
-
Danville、Virginia、美国、24541
- Danville Regional Medical Center
-
Fredericksburg、Virginia、美国、22408
- Hematology Oncology Associates of Fredericksburg Inc
-
Hampton、Virginia、美国、23666
- Virginia Oncology Associates-Hampton
-
Lynchburg、Virginia、美国、24501
- Centra Alan B Pearson Regional Cancer Center
-
Norfolk、Virginia、美国、23502
- Virginia Oncology Associates - Norfolk
-
Norton、Virginia、美国、24273
- Ballad Health Cancer Care - Norton
-
Richmond、Virginia、美国、23298
- VCU Massey Comprehensive Cancer Center
-
Roanoke、Virginia、美国、24033
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Bellingham、Washington、美国、98226
- PeaceHealth Medical Group PC
-
Everett、Washington、美国、98201
- Providence Regional Cancer Partnership
-
Mount Vernon、Washington、美国、98274
- Skagit Regional Health Cancer Care Center
-
Poulsbo、Washington、美国、98370
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Seattle、Washington、美国、98101
- Virginia Mason Medical Center
-
Seattle、Washington、美国、98122
- Swedish Medical Center-First Hill
-
Seattle、Washington、美国、98195
- University of Washington Medical Center - Montlake
-
Seattle、Washington、美国、98112
- Kaiser Permanente Washington
-
Seattle、Washington、美国、98104
- Pacific Gynecology Specialists
-
Seattle、Washington、美国、98109
- Fred Hutchinson Cancer Center
-
Seattle、Washington、美国、98133
- University of Washington Medical Center - Northwest
-
Sequim、Washington、美国、98384
- Olympic Medical Cancer Care Center
-
Silverdale、Washington、美国、98383
- Saint Joseph Medical Center Hematology and Oncology - Silverdale
-
Spokane、Washington、美国、99202
- Cancer Care Northwest - Spokane South
-
Spokane、Washington、美国、99204
- MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
-
Tacoma、Washington、美国、98405
- MultiCare Tacoma General Hospital
-
Tacoma、Washington、美国、98405
- Saint Joseph Medical Center
-
Walla Walla、Washington、美国、99362
- Providence Saint Mary Regional Cancer Center
-
Wenatchee、Washington、美国、98801
- Wenatchee Valley Hospital and Clinics
-
Yakima、Washington、美国、98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
-
Wisconsin
-
Antigo、Wisconsin、美国、54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton、Wisconsin、美国、54911
- ThedaCare Regional Cancer Center
-
Chippewa Falls、Wisconsin、美国、54729
- Marshfield Clinic-Chippewa Center
-
Eau Claire、Wisconsin、美国、54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay、Wisconsin、美国、54311
- Aurora BayCare Medical Center
-
Green Bay、Wisconsin、美国、54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay、Wisconsin、美国、54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay、Wisconsin、美国、54301-3526
- Green Bay Oncology at Saint Vincent Hospital
-
La Crosse、Wisconsin、美国、54601
- Gundersen Lutheran Medical Center
-
Madison、Wisconsin、美国、53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Manitowoc、Wisconsin、美国、54221
- Holy Family Memorial Hospital
-
Marinette、Wisconsin、美国、54143
- Bay Area Medical Center
-
Marshfield、Wisconsin、美国、54449
- Marshfield Medical Center-Marshfield
-
Milwaukee、Wisconsin、美国、53226
- Medical College of Wisconsin
-
Milwaukee、Wisconsin、美国、53215
- Aurora Saint Luke's Medical Center
-
Milwaukee、Wisconsin、美国、53233
- Aurora Sinai Medical Center
-
Minocqua、Wisconsin、美国、54548
- Marshfield Medical Center - Minocqua
-
Mukwonago、Wisconsin、美国、53149
- ProHealth D N Greenwald Center
-
Oconomowoc、Wisconsin、美国、53066
- ProHealth Oconomowoc Memorial Hospital
-
Oconto Falls、Wisconsin、美国、54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Oshkosh、Wisconsin、美国、54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Rhinelander、Wisconsin、美国、54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake、Wisconsin、美国、54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan、Wisconsin、美国、53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Stevens Point、Wisconsin、美国、54481
- Aspirus Cancer Care - Stevens Point
-
Summit、Wisconsin、美国、53066
- Aurora Medical Center in Summit
-
Two Rivers、Wisconsin、美国、54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Waukesha、Wisconsin、美国、53188
- ProHealth Waukesha Memorial Hospital
-
Wausau、Wisconsin、美国、54401
- Aspirus Cancer Care-Wausau
-
West Allis、Wisconsin、美国、53227
- Aurora West Allis Medical Center
-
Weston、Wisconsin、美国、54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids、Wisconsin、美国、54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Casper、Wyoming、美国、82609
- Rocky Mountain Oncology
-
Sheridan、Wyoming、美国、82801
- Welch Cancer Center
-
-
-
-
-
Seoul、韩国、05505
- Asan Medical Center
-
Seoul、韩国、06273
- Gangnam Severance Hospital
-
Seoul、韩国、110-744
- Seoul National University Hospital
-
Seoul、韩国、135-720
- Yongdong Severence Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Primary Surgery and Neoadjuvant Chemotherapy with Interval Cytoreductive Surgery Patients:
-
Patients must have measurable disease; at least one target lesion must have a minimum length of 1 cm in both the long and short axis (determined at the local site); for primary surgery patients, if no radiographic evidence of measurable disease is obtained prior to registration this can be based on surgical findings; imaging then would need to be completed in the 14 days between Gynecology Oncology Group (GOG) registration and chemotherapy initiation
- After GOG registration, the American College of Radiology [ACR] Imaging Core Laboratory will confirm target lesion as required per protocol; the GOG-eligibility (RECIST) scan and baseline T0 perfusion CT scans will be reviewed prior to the intermediate T1 perfusion CT time point
-
Primary Surgery Patients:
-
Patients with a histologic diagnosis of epithelial ovarian cancer, peritoneal primary carcinoma or fallopian tube cancer, stage II -IV suboptimally debulked (any residual disease > 1 cm); International Federation of Gynecology and Obstetrics (FIGO) stage is assessed following the completion of initial abdominal surgery, appropriate imaging studies and with appropriate tissue available for histologic evaluation; the minimum surgery required is an abdominal surgery providing tissue for histologic evaluation and establishing and documenting the primary site and stage; if additional surgery was performed, it should have been in accordance with appropriate surgery for ovarian or peritoneal carcinoma described in the GOG Surgical Procedures Manual
-
Neoadjuvant Chemotherapy (NAC) with Interval Cytoreductive Surgery (ICS) Patients:
-
For patients undergoing NAC-ICS, a core tissue (not fine needle aspiration) biopsy is required; the tissue must be consistent with a Müllerian origin; patients will require documentation of at least stage II or extraovarian sites of disease acquired via imaging or surgery (without attempt at cytoreduction)
-
Patients with the following histologic epithelial cell types are eligible: serous, endometrioid, clear cell, mucinous adenocarcinoma, undifferentiated carcinoma, mixed epithelial carcinoma, transitional cell carcinoma, malignant Brenner's Tumor, or adenocarcinoma not otherwise specified (N.O.S.); however, the histologic features of the tumor must be compatible with a primary Müllerian epithelial adenocarcinoma; patients may have co-existing fallopian tube carcinoma in-situ so long as the primary origin of invasive tumor is ovarian, peritoneal or fallopian tube; of note, patients with clear cell and mucinous tumors will be eligible unless there is a higher priority protocol
-
Absolute neutrophil count (ANC) greater than or equal to 1,500/mcl; this ANC cannot have been induced or supported by granulocyte colony stimulating factors
-
Platelets greater than or equal to 100,000/mcl
-
Creatinine =< 1.5 x institutional upper limit normal (ULN)
-
Bilirubin less than or equal to 1.5 x ULN
-
Serum glutamic oxaloacetic transaminase (SGOT) less than or equal to 3 x ULN
-
Alkaline phosphatase less than or equal to 2.5 x ULN
-
Neuropathy (sensory or motor) less than or equal to Common Terminology Criteria for Adverse Events (CTCAE) grade 1
-
Patients must have a GOG performance status of 0, 1, or 2
-
Patients must be entered within 12 weeks of diagnostic/staging surgery
-
Patients who have met the pre-entry requirements
-
An approved informed consent and authorization permitting release of personal health information and must be signed by the patient or guardian
-
Only applies for patients who elect to receive bevacizumab:
- Patients in this trial may receive ovarian estrogen +/- progestin replacement therapy as indicated at the lowest effective dose(s) for control of menopausal symptoms at any time, but not high-dose progestins for management of anorexia while on protocol-directed therapy or prior to disease progression due to thrombophlebitis risk
- Prothrombin time (PT) such that international normalized ratio (INR) is =< 1.5 (or an in-range INR, usually between 2 and 3, if a patient is on a stable dose of therapeutic warfarin for management of venous thrombosis including pulmonary thromboembolus) and a partial prothrombin time (PTT) < 1.2 times the upper limit of normal; (heparin, lovenox or alternative anticoagulants are acceptable)
- All patients enrolled into GOG-0262 at sites where ACRIN 6695 is open will be enrolled in the advanced imaging protocol; patients receiving adjuvant or neoadjuvant chemotherapy are eligible for ACRIN 6695; the following sentence does not apply to those patients entered after 02/08/2012: if a patient declines to participate in the perfusion imaging portion of the protocol, a clinical rationale for declination of imaging form will be completed as part of the data submission for ACRIN 6695
-
ACRIN 6695 Eligible Patients:
- Confirmation of ACRIN 6695 eligibility after the baseline T0 perfusion computed tomography (CT) will be assessed by the ACR Imaging Core Lab: At least one target lesion must have a minimum length of 1 cm in both the long and short axis (as determined by the local site), at least half of the target lesion must have attenuation greater than or equal to 10 Hounsfield Units (HU) on the unenhanced CT, and at least half of the lesion must have maximum enhancement greater than or equal to 5 HU in the perfusion CT scan (as determined by the ACR Imaging Core Lab)
Exclusion Criteria:
-
Patients with a current diagnosis of borderline epithelial ovarian tumor (formerly "tumors of low malignant potential") or recurrent invasive epithelial ovarian, primary peritoneal or fallopian tube cancer treated with surgery only (such as patients with stage I-A or I-B low grade epithelial ovarian or fallopian tube cancers) are not eligible; patients with a prior diagnosis of a borderline tumor that was surgically resected and who subsequently develop an unrelated, new invasive epithelial ovarian, peritoneal primary or fallopian tube cancer are eligible, provided that they have not received prior chemotherapy for any ovarian tumor
-
Patients who have received prior radiotherapy to any portion of the abdominal cavity or pelvis; prior radiation for localized cancer of the breast, head and neck, or skin is permitted, provided that it was completed more than three years prior to registration, and the patient remains free of recurrent or metastatic disease
-
Patients who have received prior chemotherapy for any abdominal or pelvic tumor including neo-adjuvant chemotherapy for their ovarian, primary peritoneal or fallopian tube cancer; patients may have received prior adjuvant chemotherapy for localized breast cancer, provided that it was completed more than three years prior to registration, and that the patient remains free of recurrent or metastatic disease
-
Patients who have received any targeted therapy (including but not limited to vaccines, antibodies, tyrosine kinase inhibitors) or hormonal therapy for management of their epithelial ovarian, fallopian tube or peritoneal primary cancer
-
Patients with synchronous primary endometrial cancer, or a past history of primary endometrial cancer, unless all of the following conditions are met: stage not greater than I-A, grade 1 or 2, no more than superficial myometrial invasion, without vascular or lymphatic invasion; no poorly differentiated subtypes, including papillary serous, clear cell or other FIGO grade 3 lesions
-
With the exception of non-melanoma skin cancer, patients with other invasive malignancies who had (or have) any evidence of the other cancer present within the last five years or whose previous cancer treatment contraindicates this protocol therapy
-
Patients with acute hepatitis or active infection that requires parenteral antibiotics
-
Patients with clinically significant cardiovascular disease; this includes:
- Myocardial infarction or unstable angina < 6 months prior to registration
- New York Heart Association (NYHA) grade II or greater congestive heart failure
- Serious cardiac arrhythmia requiring medication; this does not include asymptomatic, atrial fibrillation with controlled ventricular rate
-
Patients who are pregnant or nursing; patients of childbearing potential must agree to use contraceptive measures during study therapy and for at least six months after completion of bevacizumab therapy
-
Patients who have received prior therapy with any anti-vascular endothelial growth factor (VEGF) drug, including bevacizumab
-
Patients with medical history or conditions not otherwise previously specified which in the opinion of the investigator should exclude participation in this study; the investigator should feel free to consult the Statistical and Data Center (SDC) randomization desk for uncertainty in this regard
-
Patients with known allergy to cremophor or polysorbate 80
-
Only applies to patients who elect to receive bevacizumab:
-
Patients with serious non-healing wound, ulcer, or bone fracture; this includes history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 28 days; patients with granulating incisions healing by secondary intention with no evidence of fascial dehiscence or infection are eligible but require weekly wound examinations
-
Patients with active bleeding or pathologic conditions that carry high risk of bleeding, such as known bleeding disorder, coagulopathy, or tumor involving major vessels
-
Patients with history or evidence upon physical examination of central nervous system (CNS) disease, including primary brain tumor, seizures not controlled with standard medical therapy, any brain metastases, or history of cerebrovascular accident (CVA, stroke), transient ischemic attack (TIA) or subarachnoid hemorrhage within six months of the first date of treatment on this study
- Patients with CTCAE grade 2 or greater peripheral vascular disease (at least brief [< 24 hours] episodes of ischemia managed non-surgically and without permanent deficit)
- Patients with a history of CVA within six months
-
Patients with known hypersensitivity to Chinese hamster ovary cell products or other recombinant human or humanized antibodies
-
Patients with clinically significant proteinuria; urine protein should be screened by urine protein-creatinine ratio (UPCR); the UPCR has been found to correlate directly with the amount of protein excreted in a 24 hour urine collection; specifically, a UPCR of 1.0 is equivalent to 1.0 gram of protein in a 24-hour urine collection; obtain at least 4 ml of a random urine sample in a sterile container (does not have to be a 24-hour urine); send sample to lab with request for urine protein and creatinine levels (separate requests); the lab will measure protein concentration (mg/dL) and creatinine concentration (mg/dL); the UPCR is derived as follows: protein concentration (mg/dL)/creatinine (mg/dL); patients must have a UPCR < 1.0 to allow participation in the study
-
Patients with or with anticipation of invasive procedures as defined below:
- Major surgical procedure, open biopsy or significant traumatic injury within 28 days prior to the first date of bevacizumab therapy (cycle 2)
- Major surgical procedure anticipated during the course of the study; this includes, but is not limited to abdominal surgery (laparotomy or laparoscopy) prior to disease progression such as colostomy or enterostomy reversal, secondary cytoreductive surgery, or second look surgery; please consult with the SDC Randomization Desk prior to patient entry for any questions related to the classification of surgical procedures
- Any tissue biopsy, such as a core biopsy, within 7 days prior to the first date of bevacizumab therapy (cycle 2)
-
Patients with clinical symptoms or signs of gastrointestinal obstruction and who require parenteral hydration and/or nutrition
-
Patients with metastasis tumor in the parenchyma of the liver or lungs with proximity to large vessels which could make the patients at high risk of lethal hemorrhage during treatment with bevacizumab (ie. hemoptysis, liver rupture)
-
ACRIN 6695 Ineligible Patients:
- Patients with contraindication to iodinated contrast for perfusion CT imaging
- Patients who receive Metformin within 48 hours before perfusion CT imaging
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Arm I (adjuvant chemotherapy suboptimally debulked)
Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. |
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Undergo surgery Correlative studies
其他名称:
|
|
实验性的:Arm II (neoadjuvant chemotherapy)
Patients receive paclitaxel IV over 1 hour on days 1, 8, and 15 and carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 6 courses. Patients undergo interval cytoreductive surgery between courses 3 and 4. |
Given IV
其他名称:
Given IV
其他名称:
Given IV
其他名称:
Undergo surgery Correlative studies
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Progression-Free Survival
大体时间:The timeframe is from enrollment onto the study up to 3 years following enrollment.
|
First progression or death for weekly paclitaxel treatment relative to standard 3 week paclitaxel. Progression is defined using response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.0), as a 20% increase in the sum of the longest diameter of target lesions, or a measurable increase in a non-target lesion, or the appearance of new lesions. |
The timeframe is from enrollment onto the study up to 3 years following enrollment.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Median Duration of First Quartile Survival
大体时间:The timeframe is from enrollment onto the study up to 3 years after enrollment
|
First Quartile Overall Survival |
The timeframe is from enrollment onto the study up to 3 years after enrollment
|
|
Quality of Life Score as Measured by Functional Assessment of Cancer Therapy-Ovary-Total Outcome Index (Fact-O TOI)
大体时间:18 weeks after enrolling on the study, which is the time it takes to complete 6 cycles of treatment plus 3 weeks
|
Mean quality of life score after 6 cycles of study treatment estimated from a mixed model. The FACT-O-TOI is composed of three subscales: Physical Well Being (PWB) (7 Items), Functional Well Being (FWB) (7 items), and Ovarian Cancer Subscale (OCS) (12 items). Each item in the FACT-O TOI are scored using a 5-point scale (0=not at all; 1=a little bit; 2=somewhat; 3=quite a bit; 4=very much). A subscale score is computed as long as more than 50% of subscale items have been answered. A Total score of the FACT-O TOI is the summation of the three subscale scores; if more than 80% of the FACT-O TOI items provide valid responses and all three subscales have valid scores. A score of the FACT-O TOI is ranged 0-104 with a larger score indicating a more preferred state of health-related quality of life (HRQOL) |
18 weeks after enrolling on the study, which is the time it takes to complete 6 cycles of treatment plus 3 weeks
|
其他结果措施
结果测量 |
大体时间 |
|---|---|
|
通过血管分布或血容量量化的肿瘤灌注参数的变化;灌注或血流;平均运输时间;和微血管渗透性或渗透性表面积乘积
大体时间:课程 2 (T2) 开始后最多 10 天的基线 (T0)
|
课程 2 (T2) 开始后最多 10 天的基线 (T0)
|
合作者和调查者
出版物和有用的链接
一般刊物
- Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O'Malley DM, Boente MP, Michael H, Monk BJ. Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer. N Engl J Med. 2016 Feb 25;374(8):738-48. doi: 10.1056/NEJMoa1505067.
- Gaitskell K, Rogozinska E, Platt S, Chen Y, Abd El Aziz M, Tattersall A, Morrison J. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer. Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD007930. doi: 10.1002/14651858.CD007930.pub3.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
- 泌尿生殖系统疾病
- 生殖器疾病
- 内分泌系统疾病
- 泌尿生殖系统肿瘤
- 按部位分类的肿瘤
- 肿瘤
- 女性泌尿生殖系统疾病
- 女性泌尿生殖系统疾病和妊娠并发症
- 组织学类型的肿瘤
- 生殖器疾病,女性
- 肿瘤、腺体和上皮
- 卵巢疾病
- 附件疾病
- 生殖器肿瘤,女性
- 性腺疾病
- 肿瘤、结缔组织和软组织
- 肿瘤,结缔组织
- 输卵管疾病
- 卵巢肿瘤
- 肿瘤,纤维组织
- 肿瘤,纤维上皮
- 输卵管肿瘤
- 布伦纳瘤
- 氨基酸,肽和蛋白质
- 蛋白质
- 硫化合物
- 有机化学品
- 碳氢化合物
- 环磷脂
- 碳氢化合物,Alicyclic
- 碳氢化合物,循环
- 萜烯
- 抗体,单克隆,人源化
- 抗体,单克隆
- 抗体
- 免疫球蛋白
- 免疫蛋白
- 血蛋白
- 血清球蛋白
- 球蛋白
- 无机化学物质
- 协调配合物
- 税类
- 环虫
- 二萜
- 卫生保健经济学和组织
- 免疫球蛋白同种型
- 硫化物
- 阴离子
- 离子
- 电解质
- 硫化氢
- 经济学
- 贝伐单抗
- 卡铂
- 紫杉醇
- 免疫球蛋白G
- 二硫化物
- 税
其他研究编号
- NCI-2011-03812
- U10CA180868 (美国 NIH 拨款/合同)
- U10CA027469 (美国 NIH 拨款/合同)
- NCI-2011-03812 (注册表标识符:CTRP (Clinical Trial Reporting Program))
- GOG-0262/ACRIN 6695
- 11-00374
- CDR0000681448
- ACRIN 6695
- GOG-0262 (其他标识符:CTEP)
- GOG-0262 (其他标识符:NRG Oncology)
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.